TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Cardlytics ( (CDLX) ) has provided an announcement.
On December 3, 2025, Cardlytics announced that its Chief Financial Officer, Alexis DeSieno, plans to resign by March 6, 2026, or upon the appointment of her successor. Her resignation is not due to any disagreements with the company, and she will continue in an advisory role until her departure. The company has expressed gratitude for her contributions, particularly in improving the balance sheet and optimizing the cost structure.
The most recent analyst rating on (CDLX) stock is a Sell with a $1.00 price target. To see the full list of analyst forecasts on Cardlytics stock, see the CDLX Stock Forecast page.
Spark’s Take on CDLX Stock
According to Spark, TipRanks’ AI Analyst, CDLX is a Underperform.
Cardlytics’ overall stock score is primarily impacted by its poor financial performance and bearish technical indicators. The company’s high leverage and declining revenue present significant risks. While strategic initiatives and cost reductions offer some hope, the negative valuation metrics and oversold technical conditions weigh heavily on the stock’s attractiveness.
To see Spark’s full report on CDLX stock, click here.
More about Cardlytics
Average Trading Volume: 5,040,601
Technical Sentiment Signal: Sell
Current Market Cap: $65.41M
For detailed information about CDLX stock, go to TipRanks’ Stock Analysis page.